1 Min Read
Oct 4 (Reuters) - AstraZeneca Plc
* Executive Ludovic Helfgott tells Reuters $3.5 billion sales goal for Brilinta no longer attainable Further company coverage: (Reporting by UK bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.